Skip to main content
. 2020 Nov 26;10(11):e042813. doi: 10.1136/bmjopen-2020-042813

Table 1.

UK surveillance studies on COVID-19 in pregnant women and their babies

Name of study Institution Inclusion Reporting by Consent required Likely coverage in Scotland
COVID-19 in Pregnancy47 UK Obstetric Surveillance System study Any women admitted to hospital in the UK with confirmed COVID-19 at any stage of pregnancy Front-line clinicians No High
Pregnancy And Neonatal outcomes for women with COVID-1948 National Institute of Healthcare Research Imperial Biomedical Research Centre Women who have suspected or confirmed COVID-19 at any stage during pregnancy and their babies Front-line clinicians Yes Unknown as yet
Clinical Characterisation Protocol Tier 0 study17 The International Severe Acute Respiratory and emerging Infection Consortium Any patient admitted participating hospitals in the UK with confirmed COVID-19 Reporting is by research nurses No Low but may increase
Neonatal complications of COVID-1917 British
Paediatric Surveillance Unit
All babies born to mothers with COVID-19 who are admitted to neonatal care (whether the baby has COVID-19 or not) and all babies with confirmed COVID-19 in the neonatal period. Front-line clinicians. No High
Multisystem inflammatory syndrome, Kawasaki disease and toxic shock syndrome15 British Paediatric Surveillance Unit All children less than 16 years old (including neonates) with multisystem inflammatory syndrome due to SARS-CoV-2 infection or otherwise unexplained. Front-line clinicians No High
Understanding COVID-19 infection in women and their babies (periCOVID)49 Public Health England and St George’s University London Any pregnant woman with confirmed COVID-19 infection from 24 weeks gestation in England Clinicians/research midwives and nurses Yes None